ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

FIPP.GB Frontier IP Group Plc

40.50
-2.00 (-4.71%)
28 Mar 2024 - Closed
Realtime Data
Share Name Share Symbol Market Type Share ISIN Share Description
Frontier IP Group Plc AQSE:FIPP.GB Aquis Stock Exchange Ordinary Share GB00B63PS212
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.00 -4.71% 40.50 38.00 43.00 42.50 38.50 42.50 13,250 16:29:58
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Frontier IP Group plc New Portfolio Company - Tarsis Technology Limited

07/12/2016 7:00am

RNS Non-Regulatory


TIDMFIPP

Frontier IP Group plc

07 December 2016

RNS REACH

AIM: FIPP

7 December 2016

Frontier IP Group Plc

("Frontier IP" or the "Group")

New Portfolio Company - Tarsis Technology Limited

Frontier IP, which specialises in the commercialisation of intellectual property, is pleased to announce that it has received a 20 per cent. stake in Tarsis Technology Limited ("Tarsis"), the Group's third spin-out from the Department of Chemical Engineering and Biotechnology at the University of Cambridge.

Tarsis plans to develop and commercialise technology created by Dr. David Fairen-Jimenez, a Royal Society University Research Fellow at the Department of Chemical Engineering and Biotechnology at the University of Cambridge, and his research team. The technology allows slower and more controlled delivery of drugs using metal-organic frameworks (MOFs). The pharmaceutical industry has demonstrated early interest in the technology.

Frontier IP's role will be to provide commercialisation services and in-depth pharmaceutical industry expertise. Dr. Campbell Wilson, a non-executive director of Frontier IP, has been appointed as a non-executive director of Tarsis. Dr. Wilson is currently a member (and past chairman) of the Board of the UK Pharmaceutical Licensing Group and has worked in the pharmaceutical industry for over 35 years.

Dr. Campbell Wilson, Non- Executive Director of Frontier IP and Director of Tarsis, said:

"We are looking forward to working with Dr. Fairen-Jimenez on this promising opportunity. Frontier IP brings experience in commercialising IP and relationships with key players in relevant markets. Dr. Fairen-Jimenez's technology approach combined with our support and network in the pharmaceutical space can help accelerate the commercialisation for this exciting technology."

Dr. David Fairen-Jimenez, Chief Executive of Tarsis, said:

"This is a great opportunity to see the state-of-the-art materials we prepare in our labs move into the market. The synergy between Frontier IP and their experience in new ventures and in the pharmaceutical industry combined with our leading work in advanced materials for drug delivery will give a strong commercial dimension to this project."

ENDS

Enquiries

 
 Frontier IP Group Plc             T: 0131 240 1251 
 Neil Crabb, Chief Executive 
 
 Cantor Fitzgerald Europe          T: 020 7894 7000 
  (Nominated Adviser and Joint 
  Broker) 
 David Foreman, Catherine 
  Leftley, Corporate Finance 
 David Banks, Sales 
 
 Peterhouse Corporate Finance      T: 020 7469 0935 
  Limited 
  (Joint Broker) 
 Lucy Williams 
 
 Kreab                             T: 020 7074 1800 
  (Financial PR) 
 Robert Speed, Matthew Jervois 
 

Notes to Editor:

About Frontier IP Group plc

www.frontierip.co.uk.

Frontier IP specialises in assisting institutions and companies in the commercialisation and exploitation of their intellectual property. It establishes formal and informal relationships with sources of exploitable IP, principally universities. Its core business is building and growing a portfolio of equity stakes in spin-out companies by taking an active involvement in the commercialisation and funding of these businesses.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRABLBDDSUGBGLL

(END) Dow Jones Newswires

December 07, 2016 02:00 ET (07:00 GMT)

1 Year Frontier IP Chart

1 Year Frontier IP Chart

1 Month Frontier IP Chart

1 Month Frontier IP Chart

Your Recent History

Delayed Upgrade Clock